Glen Santangelo

Stock Analyst at Barclays

(3.33)
# 1,056
Out of 5,113 analysts
111
Total ratings
54.67%
Success rate
1.74%
Average return

Stocks Rated by Glen Santangelo

Phreesia
Dec 16, 2025
Maintains: Overweight
Price Target: $26$24
Current: $16.27
Upside: +47.51%
Zoetis
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $136
Current: $123.51
Upside: +10.11%
Xeris Biopharma Holdings
Dec 9, 2025
Initiates: Overweight
Price Target: $9
Current: $7.19
Upside: +25.17%
Viatris
Dec 9, 2025
Initiates: Overweight
Price Target: $15
Current: $11.94
Upside: +25.63%
Teva Pharmaceutical Industries
Dec 9, 2025
Initiates: Overweight
Price Target: $35
Current: $30.25
Upside: +15.72%
Teladoc Health
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $8.5
Current: $7.27
Upside: +16.92%
Tarsus Pharmaceuticals
Dec 9, 2025
Initiates: Overweight
Price Target: $100
Current: $79.04
Upside: +26.52%
Talkspace
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $3.5
Current: $3.54
Upside: -0.99%
Progyny
Dec 9, 2025
Initiates: Overweight
Price Target: $29
Current: $26.23
Upside: +10.56%
Phathom Pharmaceuticals
Dec 9, 2025
Initiates: Equal-Weight
Price Target: $16
Current: $16.92
Upside: -5.44%
Initiates: Equal-Weight
Price Target: $27
Current: $26.21
Upside: +3.01%
Initiates: Overweight
Price Target: $86
Current: $77.38
Upside: +11.14%
Initiates: Overweight
Price Target: $118
Current: $95.95
Upside: +22.98%
Initiates: Underweight
Price Target: $3
Current: $2.75
Upside: +9.09%
Initiates: Overweight
Price Target: $24
Current: $22.13
Upside: +8.45%
Initiates: Overweight
Price Target: $30
Current: $21.98
Upside: +36.49%
Initiates: Overweight
Price Target: $63
Current: $43.79
Upside: +43.87%
Initiates: Underweight
Price Target: $12
Current: $11.20
Upside: +7.14%
Initiates: Overweight
Price Target: $58
Current: $49.33
Upside: +17.58%
Initiates: Overweight
Price Target: $400
Current: $344.03
Upside: +16.27%
Initiates: Overweight
Price Target: $243
Current: $201.65
Upside: +20.51%
Initiates: Equal-Weight
Price Target: $8
Current: $6.98
Upside: +14.61%
Initiates: Overweight
Price Target: $100
Current: $84.06
Upside: +18.96%
Initiates: Equal-Weight
Price Target: $30
Current: $26.58
Upside: +12.87%
Initiates: Overweight
Price Target: $15
Current: $12.64
Upside: +18.67%
Initiates: Overweight
Price Target: $49
Current: $38.27
Upside: +28.05%
Initiates: Underweight
Price Target: $5
Current: $4.83
Upside: +3.52%
Initiates: Equal-Weight
Price Target: $170
Current: $159.55
Upside: +6.55%
Initiates: Underweight
Price Target: $7.5
Current: $6.83
Upside: +9.81%
Initiates: Overweight
Price Target: $960
Current: $822.09
Upside: +16.78%
Initiates: Overweight
Price Target: $850
Current: $700.91
Upside: +21.27%
Initiates: Overweight
Price Target: $48
Current: $34.63
Upside: +38.61%
Initiates: Buy
Price Target: $51
Current: $32.63
Upside: +56.30%
Reiterates: Buy
Price Target: $100
Current: $8.03
Upside: +1,145.33%
Initiates: Hold
Price Target: $55
Current: $42.75
Upside: +28.65%
Upgrades: Buy
Price Target: $31$28
Current: $2.34
Upside: +1,096.58%
Initiates: Hold
Price Target: $120
Current: $4.78
Upside: +2,410.46%
Initiates: Buy
Price Target: $36
Current: $2.47
Upside: +1,357.49%
Downgrades: Neutral
Price Target: n/a
Current: $78.30
Upside: -